It is free to register: Tell your Colleagues!
First Name:
Last Name:
Email Address:
For Free access, Please accept our terms and conditions
Terms And Conditions


Email Address:
Login Reset password

Merck USD5bn multi-tranche deal up to 30-years

Wednesday March 6th 10:14 


KENILWORTH, N.J.--()--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today priced a $5.0 billion public offering of four series of senior unsecured notes (collectively, the “Notes”). 


The Notes include:

$750 million of 2.90% notes due 2024

$1,750 million of 3.40% notes due 2029

$1,000 million of 3.90% notes due 2039

$1,500 million of 4.00% notes due 2049


Merck intends to use the net proceeds from the offering for general corporate purposes, including without limitation the repayment of outstanding commercial paper borrowings and other indebtedness with upcoming maturities. The offering is expected to close on March 7, 2019, subject to customary closing conditions. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as the active joint book-running managers for the offering. 

About Us   Contact Us   FAQ   Press Releases   Partners   Events   Dictionary   Reference Data Utility   Advertising   Legal   Technical     
Copyright © 2019 Capital Market Data Ltd. All rights reserved.